Boston Scientific Announces Enrollment Of First Patient In Benign Stricture Study Of WallFlex(R) Biliary RX Stent

Links shared publicly online about this topic.

  • 1,445
    total visits

Boston Scientific Announces Enrollment Of First Patient In Benign Stricture Study Of WallFlex(R) Biliary RX Stent

medicalnewstoday.com —

Boston Scientific Corporation (NYSE: BSX) announced that the first patient has been enrolled in a clinical trial to evaluate its WallFlex(®) Biliary RX Fully Covered Stent for the treatment of

View full resource at medicalnewstoday.com

Tags: Clinical Trial

  • Share

Most Recently Shared on January 19, 2010 at 1:09 pm By:

mnt_medicaldev MNT Medical Devices

Boston Scientific Announces Enrollment Of First Patient In Benign Stricture Study Of WallFlex(R) Biliary RX Stent http://mnt.to/3wtt

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Clinical Trials MNT Clinical Trials

Advertisement